Fool - Investing News
10 Oct 2026, 16:19 UTC · 2h ago
Impact · against what's priced in
The article provides no material catalyst for the mentioned healthcare stocks, as it focuses on ETF structural comparisons rather than company-specific fundamentals. The listed price movements are trailing indicators of recent market activity and do not introduce new valuation drivers.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish · 0 new · 3 priced in
The VanEck Biotech ETF (BBH) is highly concentrated, with its top three holdings (Amgen, Gilead Sciences, and Vertex Pharmaceuticals) comprising 36.76% of the fund.
Priced inanalysis of existing fund holdings
More positive than 79% of claims this week
The State Street SPDR S&P Pharmaceuticals ETF (XPH) utilizes an equal-weighted approach across 62 different securities.
Priced in
Continue reading
5 related stories
The company is a top holding in XPH with a 2.30% weighting and a recent price increase of 1.32%.
Read from the article alone
No priced-in read yet
The company is a top holding in XPH with a 2.23% weighting and a recent price increase of 3.37%.
Read from the article alone
No priced-in read yet
The company is listed as a top holding in XPH with a 2.47% weighting and a recent price increase of 2.85%.
Read from the article alone
Scored by the NIS engine · methodology.
Search tags
So whatThis structure mitigates idiosyncratic risk, as the largest position is only 2.47%, limiting the impact of any single company's volatility.
More positive than 54% of claims this week
Both BBH and XPH carry an identical expense ratio of 0.35%.
Priced instanding fund terms
Near neutral — 99% of claims this week are stronger
Which stocks this story touches
More positive than 57% of ticker scores this week
Mentioned as a top holding in BBH with a recent positive price movement of 1.82%.
More positive than 57% of ticker scores this week
Mentioned as a top holding in XPH with a recent positive price movement of 1.32%.
More positive than 57% of ticker scores this week
Mentioned as a top holding in BBH with a recent positive price movement of 2.77%.
More positive than 57% of ticker scores this week
Mentioned as a top holding in XPH with a recent positive price movement of 3.37%.
More positive than 57% of ticker scores this week
Mentioned as a top holding in BBH with a recent positive price movement of 1.36%.
More positive than 57% of ticker scores this week
Mentioned as a top holding in XPH with a recent positive price movement of 2.85%.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
3h ago
—
AMRX hasn't traded since this ran. Last close $19.91 (Oct 9); the reaction starts at the next open.
AMRX chart →—
MANE hasn't traded since this ran. Last close $130.90 (Oct 9); the reaction starts at the next open.
MANE chart →—
XERS hasn't traded since this ran. Last close $10.48 (Oct 9); the reaction starts at the next open.
XERS chart →
